50-year Wall Street legend: “Sell this tech stock NOW”

Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.

You can watch for it for free, right here.

Robin Seim Biography and Net Worth

Director of Omnicell

Rob Seim has served as a Director of Omnicell since January 2019. Mr. Seim joined Omnicell in January 2006 as its Chief Financial Officer for nearly 10 years and was also Executive Vice President of Finance, Administration, and Manufacturing during that time. From 2016 through 2018, Mr. Seim was President of Global Automation and Medication Adherence, which included responsibility for all of the non-U.S. business of Omnicell, several product lines, and worldwide manufacturing. Prior to joining Omnicell, Mr. Seim served as CFO of three early-stage technology companies, including Villa Montage Systems, a provider of residential broadband access management systems that he co-founded in 1999; Candera, a maker of network-based storage controllers; and Mirra, a vendor of personal backup servers which was acquired by Seagate. Previously, he held a number of senior financial management positions at Bay Networks, which was acquired by Nortel Networks in 1998. Mr. Seim began his business career in 1982 with IBM, serving in a variety of financial positions at three divisions over the course of 14 years. He has a BS in Accounting from California State University, Sacramento.

What is Robin Gene Seim's net worth?: The estimated net worth of Robin Gene Seim is at least $1.68 million as of January 4th, 2021. Mr. Seim owns 36,877 shares of Omnicell stock worth more than $1,684,910 as of November 22nd. This net worth approximation does not reflect any other assets that Mr. Seim may own. Learn More about Robin Gene Seim's net worth.
How do I contact Robin Gene Seim?: The corporate mailing address for Mr. Seim and other Omnicell executives is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. Omnicell can also be reached via phone at (877) 415-9990 and via email at [email protected]. Learn More on Robin Gene Seim's contact information.
Has Robin Gene Seim been buying or selling shares of Omnicell?: Robin Gene Seim has not been actively trading shares of Omnicell during the last ninety days. Most recently, Robin Gene Seim sold 6,686 shares of the business's stock in a transaction on Monday, August 9th. The shares were sold at an average price of $151.60, for a transaction totalling $1,013,597.60. Learn More on Robin Gene Seim's trading history.
Who are Omnicell's active insiders?: Omnicell's insider roster includes Dan Johnston (EVP), James Judson (Director), Peter Kuipers (CFO), Randall Lipps (CEO), Christine Mellon (EVP), Scott Seidelmann (EVP), Robin Seim (Director), and Joseph Spears (CAO). Learn More on Omnicell's active insiders.

Robin Gene Seim Insider Trading History at Omnicell

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/9/2021	Sell	6,686	$151.60	$1,013,597.60
1/4/2021	Sell	1,319	$119.62	$157,778.78	36,877
6/4/2018	Sell	15,658	$48.00	$751,584.00	74,121
5/15/2018	Sell	13,286	$46.48	$617,533.28	74,121
9/15/2017	Sell	9,780	$48.97	$478,926.60	55,896
8/15/2017	Sell	15,109	$50.86	$768,443.74	58,144
7/6/2016	Sell	5,302	$34.75	$184,244.50	55,420
7/1/2016	Sell	3,645	$35.00	$127,575.00	55,420
4/29/2016	Sell	6,407	$31.00	$198,617.00	59,619
4/26/2016	Sell	767	$30.00	$23,010.00	60,386
8/13/2015	Sell	23,946	$35.63	$853,195.98
7/1/2015	Sell	19,582	$37.84	$740,982.88
1/2/2015	Sell	1,948	$32.36	$63,037.28
9/15/2014	Sell	9,347	$26.32	$246,013.04
9/2/2014	Sell	27,500	$28.19	$775,225.00
7/9/2014	Sell	2,442	$28.21	$68,888.82
10/23/2013	Sell	7,664	$24.50	$187,768.00
10/21/2013	Sell	9,349	$23.76	$222,132.24
9/20/2013	Sell	27,500	$24.35	$669,625.00	69,700
7/1/2013	Sell	13,032	$20.42	$266,113.44
6/4/2013	Sell	25,000	$18.72	$468,000.00

Robin Gene Seim Buying and Selling Activity at Omnicell

Omnicell Company Overview

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Today's Range

Now: $45.69

$43.48

$45.91

50 Day Range

MA: $44.22

$39.23

$53.05

2 Week Range

Now: $45.69

$25.12

$55.74

Volume

742,150 shs

Average Volume

539,320 shs

Market Capitalization

$2.12 billion

P/E Ratio

N/A

Dividend Yield